Diagnostics Solutions Strategic Priorities slide image

Diagnostics Solutions Strategic Priorities

Roche clear leader in growing IVD market 14 billion CHF revenue in 20201 19% share as IVD market leader' 23.4 billion testsĀ¹ #1 in Clinical Chemistry & Immunodiagnostics #1 in Molecular Diagnostics #1 in Tissue Diagnostics #3 in Point-of-Care Diagnostics #1 in Workflow & IT IVD: In-Vitro Diagnostics; 1 Incl. Diabetes Care Roche 6
View entire presentation